Windrose Consulting Group at EPA, 3 - 4 March 2026

PARTNER

Gordon is a Partner at Windrose and will be a speaker at EPA 2026. He has over 14 years of experience in Healthcare across both industry and consulting. Gordon’s primary focus has been market access and pricing, but he has also held roles in brand management, sales and diagnostics.

PARTNER

Anais is a Partner at Windrose and will be in a Panel at EPA. She has over fourteen years of working experience in the Life Sciences industry globally, spanning across market access & pricing, sales & commercial, private equity, medical affairs, regulatory, and org. design.

MANAGING PARTNER

Matt heads up European consulting operations, the London and Swiss office. Over the past sixteen years Matt has led over 400 engagements spanning dozens of therapeutic categories and over 50 markets.

PARTNER

Zameer is a Partner with over twelve years of consulting experience in helping life science companies navigate the complexities of commercializing pharmaceutical and medical technologies.

Colin is a Partner at Windrose. He has over 15 years of experience in the Life Sciences industry, holding a number of senior roles focused on global pricing, market access, and commercialization strategy.

PRINCIPAL

Alessandro is a Principal at Windrose Consulting Group. He has over twenty years of experience advising global pharmaceutical and biotech companies on strategy, pricing, market access, and portfolio optimization across a wide range of therapeutic areas and geographies.

HEAD OF EMERGING MARKETS

Amy has over 20 years’ experience in custom research in emerging markets having coordinated and completed over 300 assignments spanning a spectrum of therapeutic indications - from vaccines to oncology to orphan therapeutics - in more than 40 markets worldwide. 

HEAD OF APAC

Shuang has over 15 years’ experience Pricing, Reimbursement & Market Access Experience at extensive policy maker, payer, physician and patient research across the emerging markets with primary focus on APAC especially Greater China.

ENGAGEMENT MANAGER

Georgina has gained experience in a breadth of pricing and market access and value communication projects. Georgina has contributed to early-stage forecasts and launch strategies to optimize price and access for vaccines, orphan diseases, and generics.

ENGAGEMENT MANAGER

Anjie has gained experience in pricing and market access recommendations, and conducted strategic competitive assessments for vaccines and traditional drugs. She has worked across a number of geographic locations, including US, Europe, Asia Pacific, and Africa.